| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.65e-05 | 207 | 78 | 7 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.92e-05 | 212 | 78 | 7 | GO:0017171 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 2.58e-05 | 149 | 78 | 6 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase activator activity | 3.71e-05 | 159 | 78 | 6 | GO:0019209 | |
| GeneOntologyMolecularFunction | taurine:sodium symporter activity | 4.51e-05 | 3 | 78 | 2 | GO:0005369 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 9.98e-05 | 190 | 78 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 1.49e-04 | 5 | 78 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 2.24e-04 | 6 | 78 | 2 | GO:0005332 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 2.47e-04 | 78 | 78 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 5.29e-04 | 259 | 78 | 6 | GO:0019887 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 5.33e-04 | 9 | 78 | 2 | GO:0015185 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 5.41e-04 | 363 | 78 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | kinase activity | 7.60e-04 | 764 | 78 | 10 | GO:0016301 | |
| GeneOntologyMolecularFunction | peptidase activity | 9.98e-04 | 654 | 78 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.02e-03 | 656 | 78 | 9 | GO:0008047 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 1.24e-03 | 305 | 78 | 6 | GO:0019207 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.45e-03 | 430 | 78 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 1.53e-03 | 15 | 78 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | protein antigen binding | 1.74e-03 | 16 | 78 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.75e-03 | 709 | 78 | 9 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.79e-03 | 446 | 78 | 7 | GO:0004674 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.97e-03 | 17 | 78 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | protein kinase activity | 2.34e-03 | 600 | 78 | 8 | GO:0004672 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 2.47e-03 | 19 | 78 | 2 | GO:0015355 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 2.47e-03 | 19 | 78 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.73e-03 | 20 | 78 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | molecular function activator activity | TAOK2 LGALS9C BMP1 RELN ABI1 FN1 PRKCE TAOK1 MLST8 F2 NEK9 ARF4 | 2.87e-03 | 1233 | 78 | 12 | GO:0140677 |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 3.31e-03 | 22 | 78 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 3.46e-03 | 938 | 78 | 10 | GO:0016772 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 3.61e-03 | 23 | 78 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 3.61e-03 | 23 | 78 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 4.61e-03 | 26 | 78 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 4.96e-03 | 27 | 78 | 2 | GO:0004709 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR AU-rich region binding | 5.71e-03 | 29 | 78 | 2 | GO:0035925 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 5.71e-03 | 29 | 78 | 2 | GO:0005416 | |
| GeneOntologyBiologicalProcess | negative regulation of fibrinolysis | 1.84e-05 | 14 | 78 | 3 | GO:0051918 | |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 4.83e-05 | 19 | 78 | 3 | GO:0051917 | |
| GeneOntologyBiologicalProcess | positive regulation of stress-activated protein kinase signaling cascade | 1.27e-04 | 26 | 78 | 3 | GO:0070304 | |
| GeneOntologyBiologicalProcess | positive regulation of stress-activated MAPK cascade | 1.27e-04 | 26 | 78 | 3 | GO:0032874 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 1.40e-04 | 5 | 78 | 2 | GO:0051919 | |
| GeneOntologyBiologicalProcess | positive regulation of wound healing | 1.69e-04 | 73 | 78 | 4 | GO:0090303 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 1.77e-04 | 29 | 78 | 3 | GO:0042730 | |
| GeneOntologyBiologicalProcess | muscle cell cellular homeostasis | 2.17e-04 | 31 | 78 | 3 | GO:0046716 | |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 2.17e-04 | 31 | 78 | 3 | GO:1900048 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 2.17e-04 | 31 | 78 | 3 | GO:0030194 | |
| GeneOntologyBiologicalProcess | positive regulation of coagulation | 2.86e-04 | 34 | 78 | 3 | GO:0050820 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF, modulating synaptic transmission | 2.93e-04 | 7 | 78 | 2 | GO:0099183 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 2.96e-04 | 154 | 78 | 5 | GO:0090090 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF | 3.90e-04 | 8 | 78 | 2 | GO:0099191 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 3.90e-04 | 8 | 78 | 2 | GO:0042918 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 3.90e-04 | 8 | 78 | 2 | GO:0015734 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid metabolic process | 4.06e-04 | 165 | 78 | 5 | GO:0045834 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 4.28e-04 | 93 | 78 | 4 | GO:1903036 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.29e-05 | 13 | 76 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.15e-05 | 530 | 76 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.47e-05 | 658 | 76 | 11 | GO:0030312 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.28e-04 | 656 | 76 | 10 | GO:0031012 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 2.20e-05 | 2 | 66 | 2 | MP:0009507 | |
| MousePheno | ectropion | 2.20e-05 | 2 | 66 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 2.20e-05 | 2 | 66 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 2.20e-05 | 2 | 66 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 2.20e-05 | 2 | 66 | 2 | MP:0005035 | |
| MousePheno | absent cornea epithelium | 6.57e-05 | 3 | 66 | 2 | MP:0020856 | |
| MousePheno | increased circulating fibrinogen level | 1.31e-04 | 4 | 66 | 2 | MP:0012331 | |
| MousePheno | proctitis | 1.31e-04 | 4 | 66 | 2 | MP:0003305 | |
| Domain | Groucho_enhance | 1.26e-09 | 5 | 76 | 4 | IPR009146 | |
| Domain | TLE_N | 1.26e-09 | 5 | 76 | 4 | PF03920 | |
| Domain | Groucho/TLE_N | 1.26e-09 | 5 | 76 | 4 | IPR005617 | |
| Domain | Kringle-like | 1.80e-07 | 32 | 76 | 5 | IPR013806 | |
| Domain | WD40_repeat_CS | 3.38e-07 | 164 | 76 | 8 | IPR019775 | |
| Domain | Kringle | 5.79e-07 | 17 | 76 | 4 | IPR000001 | |
| Domain | Kringle_CS | 5.79e-07 | 17 | 76 | 4 | IPR018056 | |
| Domain | KRINGLE_2 | 5.79e-07 | 17 | 76 | 4 | PS50070 | |
| Domain | Kringle | 5.79e-07 | 17 | 76 | 4 | PF00051 | |
| Domain | KRINGLE_1 | 5.79e-07 | 17 | 76 | 4 | PS00021 | |
| Domain | KR | 5.79e-07 | 17 | 76 | 4 | SM00130 | |
| Domain | WD40 | 1.03e-05 | 259 | 76 | 8 | PF00400 | |
| Domain | WD40 | 1.31e-05 | 268 | 76 | 8 | SM00320 | |
| Domain | WD40_repeat | 1.46e-05 | 272 | 76 | 8 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.71e-05 | 278 | 76 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.76e-05 | 279 | 76 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.76e-05 | 279 | 76 | 8 | PS50294 | |
| Domain | WD40_repeat_dom | 2.75e-05 | 297 | 76 | 8 | IPR017986 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 2.84e-05 | 15 | 76 | 3 | PS50915 | |
| Domain | Crystall | 2.84e-05 | 15 | 76 | 3 | PF00030 | |
| Domain | Beta/gamma_crystallin | 2.84e-05 | 15 | 76 | 3 | IPR001064 | |
| Domain | XTALbg | 2.84e-05 | 15 | 76 | 3 | SM00247 | |
| Domain | G_crystallin-rel | 5.06e-05 | 18 | 76 | 3 | IPR011024 | |
| Domain | - | 6.17e-05 | 333 | 76 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 6.43e-05 | 335 | 76 | 8 | IPR015943 | |
| Domain | SRCR | 8.17e-05 | 21 | 76 | 3 | PF00530 | |
| Domain | SR | 1.40e-04 | 25 | 76 | 3 | SM00202 | |
| Domain | - | 1.40e-04 | 25 | 76 | 3 | 3.10.250.10 | |
| Domain | SRCR_1 | 1.57e-04 | 26 | 76 | 3 | PS00420 | |
| Domain | SRCR_2 | 1.57e-04 | 26 | 76 | 3 | PS50287 | |
| Domain | SRCR-like_dom | 1.57e-04 | 26 | 76 | 3 | IPR017448 | |
| Domain | SRCR | 1.77e-04 | 27 | 76 | 3 | IPR001190 | |
| Domain | Prefoldin | 2.11e-04 | 72 | 76 | 4 | IPR009053 | |
| Domain | Peptidase_M12A | 2.43e-04 | 6 | 76 | 2 | IPR001506 | |
| Domain | Astacin | 2.43e-04 | 6 | 76 | 2 | PF01400 | |
| Domain | EGF_3 | 3.90e-04 | 235 | 76 | 6 | PS50026 | |
| Domain | EGF | 3.90e-04 | 235 | 76 | 6 | SM00181 | |
| Domain | EGF-like_dom | 5.30e-04 | 249 | 76 | 6 | IPR000742 | |
| Domain | EGF_1 | 6.01e-04 | 255 | 76 | 6 | PS00022 | |
| Domain | Ser/Thr_kinase_AS | 6.20e-04 | 357 | 76 | 7 | IPR008271 | |
| Domain | S_TKc | 6.41e-04 | 359 | 76 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 6.73e-04 | 362 | 76 | 7 | PS00108 | |
| Domain | EGF-like_CS | 6.79e-04 | 261 | 76 | 6 | IPR013032 | |
| Domain | TRYPSIN_HIS | 8.25e-04 | 103 | 76 | 4 | IPR018114 | |
| Domain | Pkinase | 9.08e-04 | 381 | 76 | 7 | PF00069 | |
| Domain | TRYPSIN_SER | 9.19e-04 | 106 | 76 | 4 | PS00135 | |
| Domain | TRYPSIN_HIS | 9.52e-04 | 107 | 76 | 4 | PS00134 | |
| Domain | Peptidase_S1A | 1.17e-03 | 113 | 76 | 4 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.24e-03 | 115 | 76 | 4 | PS50240 | |
| Domain | Tryp_SPc | 1.33e-03 | 117 | 76 | 4 | SM00020 | |
| Domain | Trypsin | 1.50e-03 | 121 | 76 | 4 | PF00089 | |
| Domain | Trypsin_dom | 1.50e-03 | 121 | 76 | 4 | IPR001254 | |
| Domain | Peptidase_S1_PA | 1.59e-03 | 123 | 76 | 4 | IPR009003 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 2.40e-03 | 18 | 76 | 2 | PS00754 | |
| Domain | PROTEIN_KINASE_ATP | 2.63e-03 | 459 | 76 | 7 | PS00107 | |
| Domain | SNF | 2.67e-03 | 19 | 76 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 2.67e-03 | 19 | 76 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 2.67e-03 | 19 | 76 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 2.67e-03 | 19 | 76 | 2 | IPR000175 | |
| Domain | Prot_kinase_dom | 3.73e-03 | 489 | 76 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 3.89e-03 | 493 | 76 | 7 | PS50011 | |
| Domain | RRM_dom_euk | 3.91e-03 | 23 | 76 | 2 | IPR003954 | |
| Domain | RRM_1 | 3.91e-03 | 23 | 76 | 2 | SM00361 | |
| Domain | Protein_kinase_ATP_BS | 4.45e-03 | 379 | 76 | 6 | IPR017441 | |
| Domain | EGF_2 | 4.51e-03 | 265 | 76 | 5 | PS01186 | |
| Domain | Ricin_B_lectin | 4.61e-03 | 25 | 76 | 2 | PF00652 | |
| Domain | G-protein_beta_WD-40_rep | 5.03e-03 | 85 | 76 | 3 | IPR020472 | |
| Domain | EGF_CA | 5.20e-03 | 86 | 76 | 3 | PF07645 | |
| Domain | - | 5.45e-03 | 663 | 76 | 8 | 2.60.40.10 | |
| Domain | RICIN | 5.77e-03 | 28 | 76 | 2 | SM00458 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 4.61e-08 | 10 | 56 | 4 | MM15156 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 2.17e-07 | 14 | 56 | 4 | M27402 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.13e-06 | 26 | 56 | 4 | MM14793 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 7.39e-06 | 32 | 56 | 4 | MM14975 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 1.27e-05 | 12 | 56 | 3 | MM1398 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.10e-05 | 14 | 56 | 3 | MM1458 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.23e-05 | 42 | 56 | 4 | M27272 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.82e-05 | 48 | 56 | 4 | M611 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 9.94e-05 | 23 | 56 | 3 | MM15279 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 9.94e-05 | 23 | 56 | 3 | MM15936 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.09e-04 | 74 | 56 | 4 | M616 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 2.23e-04 | 30 | 56 | 3 | M27566 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 2.69e-04 | 79 | 56 | 4 | MM14754 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 2.71e-04 | 32 | 56 | 3 | M165 | |
| Pathway | WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION | 3.21e-04 | 7 | 56 | 2 | M39868 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 3.56e-04 | 85 | 56 | 4 | M27079 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.62e-04 | 91 | 56 | 4 | M27101 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.35e-04 | 258 | 56 | 6 | MM14572 | |
| Pathway | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | 9.61e-04 | 49 | 56 | 3 | M92 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 9.97e-04 | 12 | 56 | 2 | M2842 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.37e-03 | 14 | 56 | 2 | M6487 | |
| Pubmed | 2.73e-11 | 4 | 81 | 4 | 8645603 | ||
| Pubmed | 1.36e-10 | 5 | 81 | 4 | 1303260 | ||
| Pubmed | 1.36e-10 | 5 | 81 | 4 | 8365415 | ||
| Pubmed | 4.08e-10 | 6 | 81 | 4 | 8573724 | ||
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 9.50e-10 | 7 | 81 | 4 | 24024827 | |
| Pubmed | 1.90e-09 | 8 | 81 | 4 | 16002402 | ||
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 1.90e-09 | 8 | 81 | 4 | 20735826 | |
| Pubmed | 5.67e-09 | 10 | 81 | 4 | 30571765 | ||
| Pubmed | 8.23e-09 | 175 | 81 | 8 | 28071719 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 8.90e-09 | 11 | 81 | 4 | 15499562 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 8808280 | ||
| Pubmed | Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. | 1.22e-08 | 3 | 81 | 3 | 30045946 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 1.33e-08 | 12 | 81 | 4 | 11266540 | |
| Pubmed | 1.92e-08 | 13 | 81 | 4 | 22735158 | ||
| Pubmed | 2.68e-08 | 14 | 81 | 4 | 17202186 | ||
| Pubmed | 3.65e-08 | 15 | 81 | 4 | 9291577 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 11290324 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 33720950 | ||
| Pubmed | 8.15e-08 | 18 | 81 | 4 | 33658226 | ||
| Pubmed | 8.15e-08 | 18 | 81 | 4 | 11731482 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 8989517 | ||
| Pubmed | Transcriptional regulation of cortical neuron migration by POU domain factors. | 1.29e-07 | 20 | 81 | 4 | 11859196 | |
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 8892234 | ||
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 2.80e-07 | 24 | 81 | 4 | 18778483 | |
| Pubmed | A comparison of Notch, Hes and Grg expression during murine embryonic and post-natal development. | 6.76e-07 | 8 | 81 | 3 | 10512199 | |
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 6.76e-07 | 8 | 81 | 3 | 28296634 | |
| Pubmed | iCLIP predicts the dual splicing effects of TIA-RNA interactions. | 5.36e-06 | 2 | 81 | 2 | 21048981 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31690812 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 30254165 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 38328826 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20675271 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 9819364 | |
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 5.36e-06 | 2 | 81 | 2 | 23943648 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11514562 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 5.36e-06 | 2 | 81 | 2 | 18420257 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 5.36e-06 | 2 | 81 | 2 | 7705657 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23041318 | ||
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 5.36e-06 | 2 | 81 | 2 | 18566672 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19752236 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17488725 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 6216475 | ||
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 5.36e-06 | 2 | 81 | 2 | 20653841 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12428098 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23341464 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 5.36e-06 | 2 | 81 | 2 | 20440070 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21316746 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24732409 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 5.36e-06 | 2 | 81 | 2 | 15456492 | |
| Pubmed | Gro/TLE enables embryonic stem cell differentiation by repressing pluripotent gene expression. | 5.36e-06 | 2 | 81 | 2 | 25446531 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 5.36e-06 | 2 | 81 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 16956791 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 25409527 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 1543918 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8704243 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 36801171 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17267741 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23702659 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 29990619 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17293777 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24696465 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24086455 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 5.36e-06 | 2 | 81 | 2 | 10854210 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16150826 | ||
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 5.36e-06 | 2 | 81 | 2 | 23527289 | |
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 5.36e-06 | 2 | 81 | 2 | 22079981 | |
| Pubmed | Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses. | 5.36e-06 | 2 | 81 | 2 | 22105072 | |
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 5.36e-06 | 2 | 81 | 2 | 9490683 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9572356 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16481742 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18983515 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34378815 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 5.36e-06 | 2 | 81 | 2 | 7586361 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24927121 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19339348 | ||
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 5.36e-06 | 2 | 81 | 2 | 21239499 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10642175 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12225871 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9770530 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10831834 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8871565 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16278295 | ||
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 5.36e-06 | 2 | 81 | 2 | 30323258 | |
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 5.36e-06 | 2 | 81 | 2 | 37971174 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9884337 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 5.36e-06 | 2 | 81 | 2 | 26473342 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10816371 | ||
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 5.36e-06 | 2 | 81 | 2 | 26791370 | |
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 5.36e-06 | 2 | 81 | 2 | 32694536 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7525077 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28830982 | ||
| Pubmed | Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities. | 5.36e-06 | 2 | 81 | 2 | 8576255 | |
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 5.36e-06 | 2 | 81 | 2 | 16052596 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17122079 | ||
| Pubmed | Fibronectin binds and enhances the activity of bone morphogenetic protein 1. | 5.36e-06 | 2 | 81 | 2 | 19617627 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20980400 | ||
| Interaction | RIPPLY2 interactions | 9.11e-07 | 20 | 77 | 4 | int:RIPPLY2 | |
| Interaction | SIX6 interactions | 8.66e-06 | 11 | 77 | 3 | int:SIX6 | |
| Interaction | HLX interactions | 1.18e-05 | 37 | 77 | 4 | int:HLX | |
| Interaction | DAZAP1 interactions | 4.61e-05 | 169 | 77 | 6 | int:DAZAP1 | |
| Interaction | CPB2 interactions | 4.97e-05 | 19 | 77 | 3 | int:CPB2 | |
| Interaction | RIPPLY1 interactions | 5.79e-05 | 55 | 77 | 4 | int:RIPPLY1 | |
| Interaction | SIX3 interactions | 5.83e-05 | 20 | 77 | 3 | int:SIX3 | |
| Interaction | TBX20 interactions | 6.79e-05 | 21 | 77 | 3 | int:TBX20 | |
| Interaction | MEP1A interactions | 1.02e-04 | 24 | 77 | 3 | int:MEP1A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 3.54e-04 | 16 | 80 | 2 | chr6q26 | |
| Cytoband | 4q28.1 | 3.54e-04 | 16 | 80 | 2 | 4q28.1 | |
| Cytoband | 6q26 | 4.51e-04 | 18 | 80 | 2 | 6q26 | |
| GeneFamily | WD repeat domain containing | 1.56e-06 | 262 | 57 | 8 | 362 | |
| GeneFamily | Beta-gamma crystallin domain containing | 2.92e-05 | 3 | 57 | 2 | 1360 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.74e-05 | 24 | 57 | 3 | 654 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.45e-04 | 6 | 57 | 2 | 894 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.28e-03 | 31 | 57 | 2 | 357 | |
| Coexpression | HALLMARK_COAGULATION | 4.17e-06 | 138 | 80 | 6 | M5946 | |
| Coexpression | NABA_ECM_REGULATORS | 8.43e-06 | 238 | 80 | 7 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 9.39e-06 | 242 | 80 | 7 | MM17062 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 9.73e-06 | 14 | 80 | 3 | M48002 | |
| Coexpression | HUANG_FOXA2_TARGETS_UP | 1.30e-05 | 47 | 80 | 4 | M15326 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | 3.68e-05 | 535 | 80 | 9 | MM3635 | |
| Coexpression | NABA_MATRISOME | MEP1B LGALS9C BMP1 RELN FN1 PRSS12 LPA TNN LOXL4 DMBT1 PLG F2 | 5.30e-05 | 1008 | 80 | 12 | MM17056 |
| Coexpression | NABA_MATRISOME | MEP1B LGALS9C BMP1 RELN FN1 PRSS12 LPA TNN LOXL4 DMBT1 PLG F2 | 6.28e-05 | 1026 | 80 | 12 | M5889 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | MEP1B RGN PSAT1 TIA1 TIAL1 GPATCH2 CRYBG1 UBR3 FBXW2 TAOK1 KLHDC10 ARF4 | 2.41e-05 | 774 | 78 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.93e-05 | 182 | 80 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 184 | 80 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 184 | 80 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 184 | 80 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 191 | 80 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 191 | 80 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 198 | 80 | 5 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 198 | 80 | 5 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.89e-05 | 198 | 80 | 5 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Control-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.51e-05 | 120 | 80 | 4 | 62d3a731d36802c9da8674a042a8604cdb86263a | |
| ToppCell | droplet-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 145 | 80 | 4 | f142b86d4da5b71c189da46cbc4beebdc387ffee | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 151 | 80 | 4 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 151 | 80 | 4 | 7758cfbe8dca849c90bd6e8bc63310e53beeb8fd | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 151 | 80 | 4 | b4a0546c1573b4b2290890307f2a5daf3a7cbb37 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 151 | 80 | 4 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 151 | 80 | 4 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | droplet-Liver-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 152 | 80 | 4 | 1febeeb7376e34b9f86c81b2cb1314ee12408864 | |
| ToppCell | droplet-Liver-nan-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 152 | 80 | 4 | faa92f7c5a6db9f1eb7d8ec930ba7c8ed9fd1bf1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-04 | 155 | 80 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-04 | 155 | 80 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 156 | 80 | 4 | 0695ac0f02d059ecf813d61d3c9d4c76d1d85834 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 156 | 80 | 4 | 1c2920f4356789a9c11d5ea1eaafb18a50b19ed7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 156 | 80 | 4 | a45fbe02cd03bd4a097f21368bc1179779ba0db8 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 157 | 80 | 4 | b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5 | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 158 | 80 | 4 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 159 | 80 | 4 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 161 | 80 | 4 | 274838cebdc7af1db32d309dfe42ef7ccd3c190b | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 162 | 80 | 4 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 163 | 80 | 4 | 03d9fa615d9d02ef98e20f28a10aaa6894dd4960 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 163 | 80 | 4 | 1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 163 | 80 | 4 | 7e82c1b7849eca895732df2da74ac6430bd9ba7a | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.17e-04 | 164 | 80 | 4 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.22e-04 | 165 | 80 | 4 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-04 | 165 | 80 | 4 | 369d77a80d6401e85ea3121ab5a252f67d5f157e | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.27e-04 | 166 | 80 | 4 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 2.32e-04 | 167 | 80 | 4 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 169 | 80 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 169 | 80 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 169 | 80 | 4 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 170 | 80 | 4 | 45de83a2231208b8e1f21061d0b91644b4a3ba93 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-04 | 172 | 80 | 4 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-04 | 172 | 80 | 4 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.66e-04 | 173 | 80 | 4 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-04 | 173 | 80 | 4 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 175 | 80 | 4 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 175 | 80 | 4 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.84e-04 | 176 | 80 | 4 | 8b5c2fb7e5e551df658b1d5fc7f607a27bab00d5 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.90e-04 | 177 | 80 | 4 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 177 | 80 | 4 | c2b8a3a149d70f77612759dea34df9e43953c566 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 177 | 80 | 4 | 384f841aa7b2d05815af7885e481f5affc55d897 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 177 | 80 | 4 | 0e9e44119653abfd270e602e5e477a15e774638f | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 177 | 80 | 4 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.96e-04 | 178 | 80 | 4 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 180 | 80 | 4 | 2405aa5699a8d8cf4c6b3dca07510e774728ac50 | |
| ToppCell | IIH-CD8-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 3.09e-04 | 180 | 80 | 4 | d1a8b25115c80e5a5bd0b8244167a98250ab9778 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 180 | 80 | 4 | 9c47852c0a723e2f5cd6898afff4c31a0da06905 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 180 | 80 | 4 | 499d5fe71e0dc20cffdf85e3b3f14eb4e83e3a3d | |
| ToppCell | IIH-plasma|IIH / Condition, Cell_class and T cell subcluster | 3.16e-04 | 181 | 80 | 4 | 13d1f31bcbac21aea91de74f51eed549ec61003e | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | IIH-plasma-|IIH / Condition, Cell_class and T cell subcluster | 3.16e-04 | 181 | 80 | 4 | 140ac43dc6b89396872f908c14c89278f6d982b2 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 3.16e-04 | 181 | 80 | 4 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-04 | 181 | 80 | 4 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 182 | 80 | 4 | e6a734fb29105093d4cbfc3d0619a825b66da034 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-04 | 182 | 80 | 4 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 182 | 80 | 4 | ccc313ecc0bfd8e2c6bb83a565b427b2310485ec | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 182 | 80 | 4 | b9f758961fb4a586ae86fa0b25edb8ce4616d644 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 3.29e-04 | 183 | 80 | 4 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-04 | 183 | 80 | 4 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 3.36e-04 | 184 | 80 | 4 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | 7f46ea82a663181957f88e4e83114aef8a78820c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | 956fb0043c0c3e4e5c4d6f58ff95faf6209c380e | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.43e-04 | 185 | 80 | 4 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-04 | 185 | 80 | 4 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 3.43e-04 | 185 | 80 | 4 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.50e-04 | 186 | 80 | 4 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-04 | 186 | 80 | 4 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | ba6ba75218efc26371cea24ddbb0e9b3e3f421ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | a58c9d1567da0961e0e295a156773d2252ee5a1a | |
| ToppCell | (4)_Lymph_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.50e-04 | 186 | 80 | 4 | 6b3afc2ae870ff73e30a60ce84fcee0eb365d809 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | 65e25a9dcef5fc71510aaf170e220deef5b2feb2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | e4f1259725160719e5fd13d76e5a707efed70013 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 3.64e-04 | 188 | 80 | 4 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 3.64e-04 | 188 | 80 | 4 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.64e-04 | 188 | 80 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 188 | 80 | 4 | 315ce1736e3a84a63a8d5dfa70d411b501cb2532 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.64e-04 | 188 | 80 | 4 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-04 | 189 | 80 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 189 | 80 | 4 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 189 | 80 | 4 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 3.72e-04 | 189 | 80 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 189 | 80 | 4 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| Computational | Genes in the cancer module 371. | 1.45e-04 | 26 | 43 | 3 | MODULE_371 | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; HL60; HT_HG-U133A | 3.35e-07 | 199 | 76 | 8 | 2936_UP | |
| Drug | bz-Ar | 1.24e-06 | 7 | 76 | 3 | CID000137302 | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; PC3; HT_HG-U133A | 4.45e-06 | 198 | 76 | 7 | 4080_DN | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; HL60; HT_HG-U133A | 4.60e-06 | 199 | 76 | 7 | 2359_UP | |
| Drug | PAMBA | 9.98e-06 | 13 | 76 | 3 | CID000065526 | |
| Drug | Rgdf peptide | 1.27e-05 | 14 | 76 | 3 | CID003080994 | |
| Drug | Aminocaproic Acid | 3.29e-05 | 3 | 76 | 2 | DB00513 | |
| Drug | AC1MJ08J | 3.29e-05 | 3 | 76 | 2 | CID003083201 | |
| Drug | 5-APA | 3.29e-05 | 3 | 76 | 2 | CID000130129 | |
| Drug | MDL 27,032 | 4.55e-05 | 21 | 76 | 3 | CID000163812 | |
| Drug | Iopanoic acid [96-83-3]; Up 200; 7uM; HL60; HT_HG-U133A | 4.72e-05 | 194 | 76 | 6 | 2965_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 2862_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 6003_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 1485_UP | |
| Drug | cobalt(II) chloride hexahydrate; Down 200; 100uM; MCF7; HG-U133A | 5.29e-05 | 198 | 76 | 6 | 383_DN | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 5994_UP | |
| Drug | Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 6521_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 5.59e-05 | 200 | 76 | 6 | 4625_DN | |
| Drug | Rdv peptide | 6.57e-05 | 4 | 76 | 2 | CID000196843 | |
| Drug | cyclopropylurea | 6.57e-05 | 4 | 76 | 2 | CID000272626 | |
| Drug | cyclooctylurea | 6.57e-05 | 4 | 76 | 2 | CID000294524 | |
| Drug | AC1L3VFE | 6.65e-05 | 65 | 76 | 4 | CID000122880 | |
| Drug | Gestodene | 8.79e-05 | 26 | 76 | 3 | ctd:C033273 | |
| Drug | AC1Q5XME | 1.09e-04 | 5 | 76 | 2 | CID000189740 | |
| Drug | methyl urethane | 1.09e-04 | 5 | 76 | 2 | CID000007752 | |
| Drug | T at 10 | 1.09e-04 | 5 | 76 | 2 | CID000480141 | |
| Drug | Cerebro | 1.10e-04 | 28 | 76 | 3 | CID000005354 | |
| Drug | iprindole | 1.10e-04 | 28 | 76 | 3 | CID000021722 | |
| Drug | 8-CPT-cAMP | 1.22e-04 | 144 | 76 | 5 | CID000001903 | |
| Drug | H743 | 1.64e-04 | 6 | 76 | 2 | CID005488509 | |
| Drug | Fqvvcg-nh2 | 1.64e-04 | 6 | 76 | 2 | CID003083094 | |
| Drug | F 29 | 1.64e-04 | 6 | 76 | 2 | CID006419426 | |
| Drug | Suramin | 1.64e-04 | 6 | 76 | 2 | DB04786 | |
| Drug | PKSI-1007 | 1.64e-04 | 6 | 76 | 2 | CID000130064 | |
| Drug | TAPNP | 1.64e-04 | 6 | 76 | 2 | CID000133888 | |
| Drug | Gly-pro-arg | 1.65e-04 | 32 | 76 | 3 | CID000170776 | |
| Drug | h x mg | 1.99e-04 | 34 | 76 | 3 | CID000001380 | |
| Drug | DuP-714 | 2.17e-04 | 35 | 76 | 3 | CID000122296 | |
| Drug | Factor Xiiib | 2.17e-04 | 35 | 76 | 3 | CID000126166 | |
| Drug | T-NK | 2.17e-04 | 35 | 76 | 3 | CID000446515 | |
| Drug | satigrel | 2.28e-04 | 7 | 76 | 2 | CID000065913 | |
| Drug | AC1N17P1 | 2.28e-04 | 7 | 76 | 2 | CID003976779 | |
| Drug | aureothricin | 2.28e-04 | 7 | 76 | 2 | CID000068460 | |
| Drug | Gly-his-arg | 2.28e-04 | 7 | 76 | 2 | CID000133872 | |
| Drug | I5B1 | 2.56e-04 | 37 | 76 | 3 | CID005487705 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; HL60; HT_HG-U133A | 2.71e-04 | 171 | 76 | 5 | 2429_DN | |
| Drug | 5'-N-ethylcarboxamidoadenosine | 2.93e-04 | 174 | 76 | 5 | CID000104795 | |
| Drug | Contraceptives, Oral, Combined | 3.04e-04 | 8 | 76 | 2 | ctd:D003277 | |
| Drug | GGACK | 3.04e-04 | 8 | 76 | 2 | CID003080903 | |
| Drug | AC1NDMP4 | 3.04e-04 | 8 | 76 | 2 | CID004628293 | |
| Drug | F 20 | 3.04e-04 | 8 | 76 | 2 | CID009547917 | |
| Drug | nitrefazole | 3.04e-04 | 8 | 76 | 2 | CID000071900 | |
| Drug | Bio-Phe-CH2Cl | 3.04e-04 | 8 | 76 | 2 | CID000083924 | |
| Drug | Bio-Arg-CH2Cl | 3.04e-04 | 8 | 76 | 2 | CID000083923 | |
| Drug | Desaa-fibrin | 3.04e-04 | 8 | 76 | 2 | CID000127263 | |
| Drug | GRGDTP | 3.04e-04 | 8 | 76 | 2 | CID004644096 | |
| Drug | S 2251 | 3.23e-04 | 40 | 76 | 3 | CID000124997 | |
| Drug | doxepin | 3.23e-04 | 40 | 76 | 3 | CID000003158 | |
| Drug | indo-1 | 3.39e-04 | 99 | 76 | 4 | CID000105060 | |
| Drug | sarcosine | 3.53e-04 | 100 | 76 | 4 | CID000001088 | |
| Drug | Grgesp | 3.74e-04 | 42 | 76 | 3 | CID000492974 | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 3.89e-04 | 185 | 76 | 5 | 7528_UP | |
| Drug | 4Amf | 3.90e-04 | 9 | 76 | 2 | CID000150955 | |
| Drug | pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid | 3.90e-04 | 9 | 76 | 2 | ctd:C077792 | |
| Drug | FK-401 | 3.90e-04 | 9 | 76 | 2 | CID000135041 | |
| Drug | tlmE | 3.90e-04 | 9 | 76 | 2 | CID000188322 | |
| Drug | dansyl-L-arginine | 3.90e-04 | 9 | 76 | 2 | CID000119895 | |
| Drug | Thiram | 3.99e-04 | 533 | 76 | 8 | ctd:D013893 | |
| Drug | Gly-pro-arg-pro | 4.01e-04 | 43 | 76 | 3 | CID000123681 | |
| Drug | Pyoverdin | 4.01e-04 | 43 | 76 | 3 | CID005289234 | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; HL60; HG-U133A | 4.18e-04 | 188 | 76 | 5 | 1622_DN | |
| Drug | dl-Lysine | 4.20e-04 | 290 | 76 | 6 | CID000000866 | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 4.29e-04 | 189 | 76 | 5 | 3084_UP | |
| Drug | Bacitracin | 4.29e-04 | 44 | 76 | 3 | ctd:D001414 | |
| Drug | maprotiline | 4.29e-04 | 44 | 76 | 3 | CID000004011 | |
| Drug | AC1OAGFB | 4.30e-04 | 539 | 76 | 8 | CID006857345 | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 4.39e-04 | 190 | 76 | 5 | 2911_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 4.50e-04 | 191 | 76 | 5 | 6776_UP | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 4.72e-04 | 193 | 76 | 5 | 3293_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 4.72e-04 | 193 | 76 | 5 | 5430_DN | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 3213_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 2893_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 3807_DN | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; PC3; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 4678_UP | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A | 4.83e-04 | 194 | 76 | 5 | 3716_UP | |
| Drug | SR 26831 | 4.86e-04 | 10 | 76 | 2 | CID000132270 | |
| Drug | amoxapine | 4.89e-04 | 46 | 76 | 3 | CID000002170 | |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 4.94e-04 | 195 | 76 | 5 | 871_UP | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 1517_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 2283_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 2833_UP | |
| Drug | trichostatin A; Up 200; 0.1uM; HL60; HG-U133A | 4.94e-04 | 195 | 76 | 5 | 364_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 2895_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 4360_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 5256_UP | |
| Drug | nickel chloride | CDK20 MEP1B RGN PSAT1 FN1 TIA1 TIAL1 P2RY2 TLE3 APBB2 FBXW2 PLG | 5.02e-04 | 1178 | 76 | 12 | ctd:C022838 |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A | 5.06e-04 | 196 | 76 | 5 | 2951_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 5.06e-04 | 196 | 76 | 5 | 2198_DN | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 5.06e-04 | 196 | 76 | 5 | 3517_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 5.06e-04 | 196 | 76 | 5 | 4415_DN | |
| Disease | calcium oxalate nephrolithiasis (biomarker_via_orthology) | 1.91e-05 | 3 | 75 | 2 | DOID:0080652 (biomarker_via_orthology) | |
| Disease | Deep Vein Thrombosis | 2.03e-05 | 21 | 75 | 3 | C0149871 | |
| Disease | Venous Thrombosis | 2.03e-05 | 21 | 75 | 3 | C0042487 | |
| Disease | cysteine-rich secretory protein LCCL domain-containing 2 measurement | 3.81e-05 | 4 | 75 | 2 | EFO_0801512 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 6.34e-05 | 5 | 75 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | plasma plasminogen measurement | 6.34e-05 | 5 | 75 | 2 | EFO_0006309 | |
| Disease | angiostatin measurement | 9.50e-05 | 6 | 75 | 2 | EFO_0008024 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 1.33e-04 | 7 | 75 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | familial Mediterranean fever (is_marker_for) | 2.27e-04 | 9 | 75 | 2 | DOID:2987 (is_marker_for) | |
| Disease | myocardial infarction | 2.70e-04 | 350 | 75 | 6 | EFO_0000612 | |
| Disease | niacinamide measurement | 4.14e-04 | 12 | 75 | 2 | EFO_0010511 | |
| Disease | Thromboembolism | 4.14e-04 | 12 | 75 | 2 | C0040038 | |
| Disease | monocyte count | CRYBG2 FN1 CD300LF P2RY2 LPA PRKCE ADGRF5 PLG F2 RAI1 MAP3K19 | 4.86e-04 | 1320 | 75 | 11 | EFO_0005091 |
| Disease | Alcohol abuse | 6.72e-04 | 67 | 75 | 3 | C0085762 | |
| Disease | central nervous system disease (implicated_via_orthology) | 7.48e-04 | 16 | 75 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | coronary artery disease | 8.62e-04 | 1194 | 75 | 10 | EFO_0001645 | |
| Disease | glomerulonephritis (is_marker_for) | 1.06e-03 | 19 | 75 | 2 | DOID:2921 (is_marker_for) | |
| Disease | alpha-tocopherol measurement | 1.18e-03 | 20 | 75 | 2 | EFO_0007898 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.65e-03 | 335 | 75 | 5 | EFO_0009931 | |
| Disease | Coronary heart disease | 1.70e-03 | 24 | 75 | 2 | C0010068 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.08e-03 | 99 | 75 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.26e-03 | 102 | 75 | 3 | EFO_0004329, EFO_0004611 | |
| Disease | Weight Gain | 2.26e-03 | 102 | 75 | 3 | C0043094 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 2.48e-03 | 29 | 75 | 2 | DOID:11984 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVGQNVGWYVGVCRD | 346 | Q6UXE8 | |
| YDQGVDLWSVGCIMG | 181 | Q8IZL9 | |
| YAGEKCGNVWEENRS | 96 | O94986 | |
| TQVGWHGETYCLVGG | 46 | A0A0U1RQF7 | |
| SYCKNDIRDTVGIWG | 451 | Q92870 | |
| NGSWGGRGEVITTYC | 56 | P49419 | |
| VEYKNICFTVWDVGG | 56 | P84085 | |
| AIDGGWVARTGYCSV | 3166 | Q6V0I7 | |
| RTKHICVYWEGSEGG | 136 | Q86SQ3 | |
| IYKGLVQTGAWGCFD | 1931 | Q96DT5 | |
| DGWYEGVCNRVTGLF | 481 | Q8IZP0 | |
| RYVGETDFAKGEWCG | 236 | Q9UDT6 | |
| GGVDCEWVIVAEEGY | 886 | P13497 | |
| EACAVWTGGVYLVAG | 1826 | Q7Z5J4 | |
| FGEYCSSENGKGREW | 121 | O60268 | |
| GIVLCGDEEGNVWLY | 566 | Q9UFC0 | |
| DGKVYDITEWAGCQR | 591 | Q6Y2X3 | |
| EVYYRGQWGTVCDDG | 401 | P56730 | |
| TEGIWELVTGGVFYC | 206 | Q8IY49 | |
| GKGLEWVSVIYSCGS | 61 | A0A0C4DH42 | |
| FGEQGVTVGCWDTYR | 661 | Q96JB6 | |
| TRNKEVYSWGCGEYG | 496 | Q8TD19 | |
| VGEGRACWSLGNAYV | 326 | Q86YR5 | |
| YVVCNTRQKGTWGPE | 71 | Q6DKI2 | |
| CRDFIWGVIGKQGYQ | 186 | Q02156 | |
| GYCSGWLVEKVEVTN | 2021 | Q8IVV2 | |
| LWCVETGEIKREYGG | 296 | Q9BVC4 | |
| AKQYGGWEVKCELSG | 531 | Q96KP1 | |
| CGGYNGEVILGDIWK | 331 | Q6PID8 | |
| SGQFDLGKCEIGWAY | 156 | Q9Y693 | |
| TINGTWDGDELGYRC | 11 | P41231 | |
| LWYKITGAQVGTGCG | 1461 | P78509 | |
| EWGDSGVYQCVIKGR | 86 | Q9HB29 | |
| CHEGGQSYKIGDTWR | 141 | P02751 | |
| RCNSIKVEGGTWAVY | 36 | P22914 | |
| YWCGIEKTGNDLGVT | 106 | Q8TDQ1 | |
| VLGGCWVGYEKEGFR | 1211 | Q8N1P7 | |
| EKGVYRNCEDWGAGN | 1321 | Q8N1P7 | |
| KYILQGVTSWGLGCA | 2001 | P08519 | |
| KSCRVSGGSWVVYDG | 1446 | Q9Y4K1 | |
| WFYEKESGGACGITG | 286 | Q9NW75 | |
| KLWDVSTGQCVYGIQ | 171 | Q9UKT8 | |
| GRVEVLYRGSWGTVC | 1391 | Q9UGM3 | |
| GRVEVLYRGSWGTVC | 1651 | Q9UGM3 | |
| GAATEGCKDGWVYNR | 101 | A6NK97 | |
| GETNYISVFKGSGCW | 111 | Q16820 | |
| AKGGDISVCEWYQRV | 46 | P14854 | |
| ESGYGRKSDIWSIGC | 1241 | Q56UN5 | |
| GKLWCFTVDRGSGVV | 491 | Q13049 | |
| VGFYLGTWRDGNVVC | 171 | Q96GJ1 | |
| IGQYTSEGGITCWEK | 101 | P31641 | |
| LVGVVSWGYGCTLRD | 276 | A6NIE9 | |
| GRCADYVVTGAWSAK | 96 | Q9Y617 | |
| LSKDGYGGWQDLVCL | 226 | Q9Y6U7 | |
| QYDGKVDVWSLGITC | 201 | Q7L7X3 | |
| QYDGKVDVWSLGITC | 201 | Q9UL54 | |
| EGKLWVACYNGGRVI | 211 | Q15493 | |
| KYILQGVTSWGLGCA | 771 | P00747 | |
| GGTITYKCVGSQWEE | 701 | Q8IZF2 | |
| VEYKNICFTVWDVGG | 56 | P18085 | |
| CVINTCGWVKGSGYQ | 226 | Q92989 | |
| TDCTRTGLGGYWGNK | 526 | Q15735 | |
| TRHVYTGGKGCVKVW | 496 | Q04724 | |
| QGGDVLEWIQRYGAC | 106 | Q6SA08 | |
| LQVYCDMETDGGGWI | 1096 | Q9UQP3 | |
| HVYTGGKGCVKVWDI | 501 | Q04727 | |
| IGVGGCWFAYTQNKT | 226 | Q9P246 | |
| GWEGAKYAVAVGSLC | 331 | P30825 | |
| GGSYWKEGCLQSELI | 246 | Q5TF21 | |
| SKVTCGRGGWVYVLH | 56 | Q96FX7 | |
| VYVWYGGQECTGLVE | 81 | Q9H8N7 | |
| GQFTSEGGITCWRKV | 111 | P48066 | |
| GGDYIVSIQLVDCKW | 451 | A8MT19 | |
| RCGGWSAKFVDVQYS | 2766 | Q86WI1 | |
| SKGLTVVDVYQGWCG | 26 | Q86XW9 | |
| VYTGGKGCVKIWDIS | 501 | Q04726 | |
| EDGCVYGWETRSGQL | 41 | Q5JTN6 | |
| GWEGGVYVQTCGHTL | 1316 | Q6ZT12 | |
| GIVSWGEGCDRDGKY | 586 | P00734 | |
| HVYTGGKGCVKVWDV | 471 | Q04725 | |
| NGTTIEGHVVKCYWG | 261 | Q01085 | |
| GTTIEGHVVKCYWGK | 271 | P31483 | |
| CYGDLVQELWSGTQK | 786 | Q8NFA0 |